Monocyte phenotype, their phagocytic capacity as well as the cytokine production from 10 patients with sepsis with low interleukin-6 (IL-6) serum concentrations (!1000 pg/mL) and 8 patients with sepsis with high IL-6 (у1000 pg/mL) plasma concentrations were investigated within 24 hours of fulfilling the criteria for sepsis. Monocytes from patients with high IL-6 levels had higher levels of human leukocyte antigen (HLA)-DR, HLA-ABC, CD64, and CD71, and the production of tumor necrosis factor-a (TNF-a) and IL-8, as well as the capacity of monocytes to phagocytose, was significantly elevated. Of 8 patients with high levels of plasma IL-6, 4 patients died. In contrast, all 10 patients with low plasma IL-6 concentrations survived until day 28. Patients who died had constant high IL-6 concentrations during the first 3 days, whereas IL-6 levels in patients who survived decreased by 88%. Our data indicate that IL-6 levels are a better prognostic parameter in the early phase of sepsis than the monocyte HLA-DR expression.
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Septic shock is the most common cause of death in intensive care units (ICU). Despite modern intensive care and antibiotic treatment, the mortality of sepsis is high, ranging 30%-40% in patients without shock and р70% in patients with septic shock [1, 2] . The role of the immune system in the pathogenesis of septic disease has been widely documented. When local infection develops into systemic infection and signs of sepsis are apparent, a strong systemic reaction occurs, and cytokines, which normally are restricted to areas of local injury, can be detected systemically contributing to symptoms of septic shock [3] . One of these cytokines, TNF-a (cachectin), is regarded as a central mediator of immune regulation and of the pathophysiological changes associated with bacteremia and sepsis syndrome [4] . Other cytokines, such as IL-1, act synergistically with TNF-a, stimulating the release of mediators such as IL-6, IL-8, IL-10, IL-13, and transforming growth factor-b (TGFb), which participate in the host inflammatory response and the pathogenesis of sepsis and septic shock [5] [6] [7] [8] . Plasma TNFa concentrations have been found to be increased in patients with both gram-negative and gram-positive infectious disease [9, 10] . Overproduction of TNF-a and, in particular, of IL-6 have been shown to correlate with poor outcome in patients with severe sepsis and septic shock [11] [12] [13] [14] . TNF-a, IL-1, and IL-6 are typical examples of multifunctional cytokines. They are mainly produced by activated monocytes [15] [16] [17] . Other cell types, including T and B lymphocytes, neutrophils, eosinophils, natural killer cells, mast cells, basophils, endothelial cells, fibroblasts, keratinocytes, and astrocytes were also found to be a source of a large variety of cytokines [15] .
Monocytes and macrophages play a central role in both specific and nonspecific immunity against bacterial, viral, and fungal infection. Monocytes express a wide range of surface markers, such as Fc receptors for IgG (FcgR) and complement receptors (CR), which are very effective in the binding and endocytosis of opsonized particles [18, 19] . Furthermore, monocytes from healthy people also express high levels of major histocompatibility complex (MHC) class II molecules, which play a crucial role in antigen (Ag) presentation to T helper lymphocytes [20] . Other investigations have shown that changes in MHC class II Ag expression on monocytes are indicative of developing infections after major surgery and that mortality and recovery rates among patients with infection and sepsis are linked to levels of human leukocyte antigen (HLA)-DR expression [21] , monocyte deactivation [22] , and endogenously produced IL-10 and TGF-b [23] . In addition, prostaglandin E 2 and cyclic adenosine monophosphate contribute to this phenomenon, both directly and indirectly, by IL-10 induction [24, 25] . Recently, it was shown that the use of IFN-g for the treat- 10 4 NOTE. Patients in the low IL-6 group had IL-6 levels of !1000 pg/mL. Patients in the high IL-6 group had IL-6 levels of у1000 pg/mL. APACHE, acute physiology and chronic health evaluation; SAPS, simplified acute physiology score. ment of patients with sepsis restored reduced HLA-DR expression on monocytes and rescued patients from severe sepsis [22, 26, 27] .
In this study, we investigated the relationship between high and low concentrations of IL-6 in the plasma of patients with severe sepsis. We also assessed in vitro cytokine production and the phenotype of monocytes, as well as their phagocytic properties; and we studied whether these parameters are important prognostic markers.
Materials and Methods
Hospitalized patients with diagnoses of sepsis made on the basis of criteria originally proposed by Bone et al. [28] were eligible for enrollment into the study. In addition, all patients had to meet all of the following 5 criteria for sepsis within 24 h of one another: (1) definitive clinical evidence to support an infectious origin or the presumptive diagnosis of sepsis syndrome; (2) hyperthermia (body temperature у38.0ЊC) or hypothermia (body temperature р35.6ЊC) measured as core temperature; (3) tachycardia, defined as a heart rate of у90 beats/min in the absence of receiving a badrenergic receptor blocker; (4) tachypnea, defined as a respiratory rate of у20 breaths/min or the need for mechanical ventilation; and (5) hypotension, defined as a systolic blood pressure of р90 mm Hg or a sustained drop in the systolic blood pressure of у40 mm Hg in the presence of an adequate fluid challenge. Systemic toxicity or poor-end organ perfusion were defined by у2 of the following criteria: metabolic acidosis, arterial hypoxia, acute renal failure, coagulation abnormality, unexplained decrease in platelet count, and acute deterioration of the patient's mental status.
Blood samples were drawn into Vacutainer tubes (Becton Dickinson, San José, CA) that contained EDTA and were centrifuged. Plasma was harvested and deep frozen. The IL-6 concentration was determined semiquantitatively by means of a bedside stick test developed by Knoll AG (Ludwigshafen, Germany). This test allows for the rapid identification of IL-6 with a threshold sensitivity of IL-6, 1000 pg/mL. The test contained an anti-IL-6 mouse monoclonal antibody (MAb) coupled to blue latex, 1.0 mg of mouse anti-IL-6 MAb, 0.5 mg of human recombinant IL-6, 1.0 mg of an irrelevant MAb, and 5.6 mg of buffer components. It was performed under routine ICU conditions, and results were obtained in 20 min. Ten patients with IL-6 levels !1000 pg/mL were considered to be negative by this test, whereas 8 patients showed IL-6 levels у1000 pg/mL.
In addition to the semiquantitative IL-6 bedside test, IL-6, IL-8, and TNF-a were measured by ELISA (Medgenix, Fleurus, Belgium) in 2 independent test runs. Blood was drawn into EDTAcontaining Vacutainer tubes and was immediately centrifuged at 2000 g at 4ЊC for 10 min. Serum was separated, and aliquots were frozen at Ϫ70ЊC until analysis. The arithmetic mean of both test runs was considered the final result. TNF-a, IL-6, and IL-8 were analyzed at baseline. In addition, IL-6 was measured at 8, 24, 48, and 72 h after baseline.
Blood samples for study were drawn at baseline from all patients and were analyzed by immunofluorescence and flow cytometry. A total of 100 mL of whole blood was incubated with MAb for 30 min at room temperature in darkness. Each probe, except for the isotype control, was triple stained with the anti-CD14 and anti-HLA-DR MAb. Next, RBC were lysed; leukocytes were stabilized and fixed by Multi-Q-Prep (Coulter, Hialeah, FL). Finally, cells were washed 3 times and were immediately analyzed by flow cytometry on an Epics XL-MCL (Coulter), as described elsewhere [27] . The following MAbs were used: anti-HLA-DR (phycoerythrin [PE]-conjugated; Becton Dickinson), anti-CD14 (PE/Cy-5), anti-CR1/CD35, anti-CR3/CD11b, anti-ICAM-1/CD54, anti-transferrin/CD71, and anti-CD33 (all fluorescein isothiocyanate [FITC] conjugated; Immunotech, Marseille, France); anti-FcgRI/CD64 (FITC; Medarex, West Lebanon, NH); and anti-HLA-ABC (FITC; Cymbus Bioscience, Southampton, UK). Monocytes were gated and 2500 CD14 ϩ cells were counted [29, 30] . Data were expressed as a percentage and as mean channel fluorescence (MCF).
Phagocytosis was determined from 100 mL of heparinized whole blood and Ig-opsonized and FITC-conjugated Escherichia coli (Phagotest; Orpegen, Heidelberg, Germany), which was incubated for 10 min at 37ЊC. Cells were then cooled on ice to stop phagocytic activity. Leukocytes were additionally stained with an anti-CD14 MAb (My4, PE) to detect monocytes. Finally, cells were washed 3 times, and the percentage and the MCF of CD14 ϩ phagocytic cells were determined by flow cytometry analysis [30] .
Data were statistically analyzed for each group and every time point. Comparison between groups was performed by means of a paired t test. In cases of measurements done at several time points, the time effect and group-time interactions were also determined. For multiple comparisons, adjustments according to Tukey-Kramer were made. Probability values were 2-sided, and was P ! .05 considered to be statistically significant. We used SPSS, version 7.5.2G (SPSS, Chicago).
Results
The demographic characteristics and the clinical features of the recruited patients are depicted in table 1. The IL-6 concentration was measured in the plasma of 18 patients with sepsis. These patients were divided into 2 groups: 10 patients with low plasma concentration (IL-6, !1000 pg/mL; negative Table 2 . Differential blood cell count and hematological parameters of patients with low and high plasma levels of interleukin-6 (IL-6).
Hematological parameter
Patients with low IL-6 levels (n p 10)
Patients with high IL-6 levels (n p 8) Table 3 . Production of interleukin-6 (IL-6), interleukin-8 (IL-8), and tumor necrosis factor-a (TNF-a) by peripheral blood mononuclear cells from patients with low and high plasma levels of IL-6.
Cytokine, pg/mL
Patients with high IL-6 levels (np 8) IL-6 bedside test) and 8 patients with high plasma concentration (IL-6, у1000 pg/mL; a positive IL-6 bedside test), referred to as the low IL-6 and the high IL-6 group, respectively. There were no significant differences between the groups with regard to mean age, sex, body weight, and APACHE II (Acute Physiology and Chronic Health Evaluation) and SAPS (Simplified Acute Physiology Score) scores. In the members of the low IL-6 group, all patients were alive after 28 days, compared with 4 of 8 patients in the high IL-6 group. As shown in table 2, patients with high IL-6 concentrations showed significantly lower leukocyte and thrombocyte counts than did patients in the low IL-6 group. There were no significant differences in RBC counts, as well as in hematocrit and hemoglobin levels.
The baseline concentrations of IL-6, IL-8, and TNF-a were significantly elevated in the patients with high IL-6 levels (table  3) . Those members of this group who did not die showed an 88.5% reduction in IL-6 levels, compared with baseline levels, during the 3 days after the patients fulfilled the criteria for sepsis. In contrast, IL-6 production in patients who died remained at high levels during this time (table 4) .
The expression of cell surface Ag was investigated at baseline. As shown in table 5, the percentage of HLA-DR bearing monocytes (CD14 ϩ cells) as well as the density of HLA-DR were significantly elevated in the high IL-6 group, compared with the low IL-6 group. Furthermore, expression of the CD64/ FcgRI, CD71/transferrin receptor, and HLA-ABC was also significantly upregulated in the high IL-6 group, as shown by an increase in MCF, whereas there was no significant difference in the expression of CR1/CD35, CR3/CD11b, ICAM-1/CD54, and CD33 between members of both groups (table 5) .
Monocytes were also investigated for their ability to phagocytose-opsonized E. coli. As shown in figure 1 , monocytes from patients in the high IL-6 group showed a significantly higher percentage of CD14 ϩ cells phagocytosing E. coli as well as a significantly higher number of ingested particles per cell, as indicated by the MCF.
Discussion
Mononuclear phagocytes are central elements in host defense against a variety of invading microorganisms, and they are the main source of TNF-a in sepsis [4] [5] [6] 17] . In the present study, expression of cell surface Ag on monocytes from patients with sepsis who had high and low levels of IL-6 and their phagocytic properties were investigated. The gene products HLA-DR, DQ, and DP (of the MHC class II complex) and HLA-ABC (of the MHC class I complex) are essential in presentation of intracellularly processed Ag to CD4 ϩ and CD8 ϩ T cells, respectively [20] . Monocytes express constitutively FcgRI/CD64, FcgRII/CD32, and CR3 (CD11b/CD18). These cell surface structures are important in the recognition and internalization of opsonized particles [18, 20] . Other molecules, such as FcgRIII/CD16 and transferrin/CD71, are poorly expressed on resting blood monocytes.
The most striking result of our study is that patients differentiate on the basis of IL-6 levels also have significantly different TNF-a, IL-8, and HLA-DR levels. This finding is in accordance with findings from other studies in that the mortality rate of patients with sepsis is associated with high IL-6 levels [13, 14, 31] . Of interest, HLA-DR expression was lower in members of the low IL-6 group, which does not fit earlier studies indicating that HLA-DR expression !30% is predictive of death [32] . We and others have demonstrated that HLA-DR expression on monocytes is downregulated during the period when surgery is performed [33, 34] . However, after repeated surgery, as performed for patients with acute pancreatitis, the repeated surgical stress has no additional influence on HLA-DR expression [35] .
The expression of HLA-DR is mainly regulated by cytokines. Several investigators have demonstrated that use of IFN-g for the treatment of patients with sepsis leads to rescue from severe sepsis and to enhanced HLA-DR expression [22, 26, 27] . In cell culture experiments, we have already shown in vitro that the expression of HLA-DR and FcgRI/CD64, as well as the ability of monocytes to phagocytose Ig-opsonized E. coli, is augmented by IL-6 and TNF-a [36, 37] . The current study seems to confirm these in vitro results, because patients with high levels of IL-6 and TNF-a have elevated HLA-DR expression and an increased monocyte phagocytic capacity, compared with patients with low IL-6 levels. However, taking into account the fact that the IL-6 levels discriminated between severe sepsis and mild sepsis, a stronger reduction of HLA-DR would have been ex- NOTE. The IL-6 baseline value for each patient with high IL-6 levels (у1000 pg/mL) was set to 100%, and changes from baseline values were calculated as the . The changes, over time, in IL-6 production between patients percentage ‫ע‬ SD who lived and patients who died was statistically significant ( ). P ! .01 Figure 1 . One hundred microliters of whole blood and of Ig-and complement-opsonized fluorescein isothiocyanate-conjugated Escherichia coli were incubated for 10 min at 37ЊC. Next, cells were cooled on ice to stop phagocytic activity. Cells were additionally stained with an anti-CD14 monoclonal antibody (My4, phycoerythrin) to detect monocytes. Finally, cells were washed 3 times, and the percentage (A) and the mean channel fluorescence intensity (MCF; B) of CD14 ϩ phagocytic cells were determined by fluorescence-activated cell-sorter analysis. * statistically significant between groups ( ). P ! .05 pected in members of the high IL-6 group rather than in members of the low IL-6 group.
Although the patients we studied were recruited into the study within 24 h after fulfillment of the criteria for sepsis, a possible explanation for these contradictory findings is that, in patients with low IL-6 levels, progressive immunosuppression has already taken place. It is known that the course of severe sepsis is at least biphasic. In the first few hours after microbial colonization, an exaggerated inflammatory response is detected in which proinflammatory cytokines are excessively secreted. In particular, IL-8 is rapidly enhanced upon lipopolysaccharide stimulation, with a maximum peak after 4-8 h [38] . The phase of the overshooting immune system is then followed by a progressive immunosuppression with a continuous reduction of HLA-DR in monocytes. These patients showed a reduced constitutive and ex vivo lipopolysaccharide-induced cytokine production; particularly the production of TNF-a was dramatically suppressed [21, 39] . In our study, patients with lowered plasma levels of IL-6, IL-8, and TNF-a, combined with reduced monocyte HLA-DR expression and phagocytic capacity, are perhaps in a transition from hyperactivity to suppression of the immune system. High levels of IL-6 have been shown to be the best single predictor of mortality in patients with sepsis [14, 31] . Analysis of the IL-6 data, which were collected with the novel IL-6 bedside test that allowed semiquantitative results within 30 min, indicated that mortality of members of the high IL-6 group was considerable (50%) compared with that in the low IL-6 group (0%). In the patients who survived, IL-6 concentration decreased steadily, and at day 3, they reached 88.2% reduction from baseline levels. In contrast, patients who died did not show marked changes in the concentration of IL-6 during the first 3 days. However, APACHE II and SAPS scores were not significantly different from those obtained for patients with sepsis at the screening phase, which indicates a high specificity for the correlation between proinflammatory cytokine production and the clinical outcome.
In conclusion, analysis of our data shows that patients with high IL-6 levels of у1000 pg/mL and enhanced IL-8 and TNFa concentrations still have an activated immune system, as indicated by a high production of proinflammatory cytokines and enhanced HLA-DR, FcgRI/CD64, and CD71 expression on monocytes as well as an increase in their phagocytic properties, in comparison with patients with low IL-6 levels. These in vivo data are in agreement with previous in vitro results, showing a close relationship between IL-6 and TNF-a expression and monocyte phenotype. Our studies further emphasize that IL-6 is a reliable prognostic marker in patients with severe sepsis and suggest that our semiquantitative IL-6 bedside test, which can be easily and rapidly performed, may be useful in screening and monitoring of patients with sepsis.
